What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review.
about
Genetic heterogeneity in Alzheimer disease and implications for treatment strategiesCurrent concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease.A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease.Children of persons with Alzheimer disease: what does the future hold?Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease.Propositional density and apolipoprotein E genotype among persons at risk for familial Alzheimer's disease.Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype.Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease.New genes and new insights from old genes: update on Alzheimer disease.The effects of different familial Alzheimer's disease mutations on APP processing in vivo.Dominantly Inherited Alzheimer Network: facilitating research and clinical trials.Current therapeutic targets for the treatment of Alzheimer's disease.Perspectives on episodic-like and episodic memory.The Cambridge Semantic Memory Test Battery: detection of semantic deficits in semantic dementia and Alzheimer's disease.Nervous system disorders across the life course in resource-limited settings.Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease.Object recognition as a measure of memory in 1-2 years old transgenic minipigs carrying the APPsw mutation for Alzheimer's disease.Children of Alzheimer patients: an overview.Aging related cognitive changes associated with Alzheimer's disease in Down syndrome.
P2860
Q26995802-1A18852F-C78F-42A6-8F5F-8072DD6D4F87Q33921483-BDA05698-E75C-44BD-BE38-2927BC1C31DCQ35879102-565D0F3F-15B8-442E-9DED-FAFB2CA11972Q36039851-45490AEA-AA8D-436F-AAEA-79ED2131B732Q36233510-1E663AC4-9D80-4F07-A517-B1360C8CA0BFQ36526089-7248E920-7750-4E01-A3A4-315986ABD0A4Q36888445-01B81DD0-64A6-4B01-8205-781544A0F4E3Q36966011-AA63F0DF-311F-4DF5-9420-3327071FFF45Q37560444-A70E3EDA-15BC-4471-9B51-F23E4432346AQ37645358-3B3FE6AD-A6EF-4451-AD6A-32323D7DBD47Q37689963-1E341112-B3EE-444B-A9E6-902E43F90690Q37737296-32894781-408E-4BAA-BB77-42ED5058F823Q38101555-13CBEA77-0DEC-41EF-9767-A1B6E96123D0Q38374227-DB3ED8C8-9F2E-40C4-8814-ABFF3B46AD50Q38637214-4529DA81-3D12-43DC-AC6C-92C116FAC9CEQ47587917-5FDFEA5B-B250-460E-9E26-7567F2DFE88BQ50803794-C061145E-2FE4-4167-8FBF-98D3FEFD28C7Q53273836-710EB7C8-9949-4304-B87F-2A158B750BF6Q55332987-2B0CFA8A-6008-4900-B634-148808BE1940
P2860
What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
What the study of persons at r ...... ges of the disorder: a review.
@ast
What the study of persons at r ...... ges of the disorder: a review.
@en
type
label
What the study of persons at r ...... ges of the disorder: a review.
@ast
What the study of persons at r ...... ges of the disorder: a review.
@en
prefLabel
What the study of persons at r ...... ges of the disorder: a review.
@ast
What the study of persons at r ...... ges of the disorder: a review.
@en
P2860
P356
P1476
What the study of persons at r ...... ges of the disorder: a review.
@en
P2093
John M Ringman
P2860
P304
P356
10.1177/0891988705281878
P577
2005-12-01T00:00:00Z